Tags

Type your tag names separated by a space and hit enter

Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Am J Kidney Dis. 2021 01; 77(1):56-73.e1.AJ

Abstract

RATIONALE & OBJECTIVE

Identification of novel risk factors for chronic kidney disease (CKD) progression may inform mechanistic investigations and improve identification of high-risk subgroups. The current study aimed to characterize CKD progression across levels of numerous risk factors and identify independent risk factors for CKD progression among those with and without diabetes.

STUDY DESIGN

The Chronic Renal Insufficiency Cohort (CRIC) Study is a prospective cohort study of adults with CKD conducted at 7 US clinical centers.

SETTING & PARTICIPANTS

Participants (N=3,379) had up to 12.3 years of follow-up; 47% had diabetes.

PREDICTORS

30 risk factors for CKD progression across sociodemographic, behavioral, clinical, and biochemical domains at baseline.

OUTCOMES

Study outcomes were estimated glomerular filtration rate (eGFR) slope and the composite of halving of eGFR or initiation of kidney replacement therapy.

ANALYTICAL APPROACH

Stepwise selection of independent risk factors was performed stratified by diabetes status using linear mixed-effects and Cox proportional hazards models.

RESULTS

Among those without and with diabetes, respectively, mean eGFR slope was-1.4±3.3 and-2.7±4.7mL/min/1.73m2 per year. Among participants with diabetes, multivariable-adjusted hazard of the composite outcome was approximately 2-fold or greater with higher levels of the inflammatory chemokine CXCL12, the cardiac marker N-terminal pro-B-type natriuretic peptide (NT-proBNP), and the kidney injury marker urinary neutrophil gelatinase-associated lipocalin (NGAL). Among those without diabetes, low serum bicarbonate and higher high-sensitivity troponin T, NT-proBNP, and urinary NGAL levels were all significantly associated with a 1.5-fold or greater rate of the composite outcome.

LIMITATIONS

The observational study design precludes causal inference.

CONCLUSIONS

Strong associations for cardiac markers, plasma CXCL12, and urinary NGAL are comparable to that of systolic blood pressure≥140mm Hg, a well-established risk factor for CKD progression. This warrants further investigation into the potential mechanisms that these markers indicate and opportunities to use them to improve risk stratification.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Anderson AH
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. Electronic address: aanderson5@tulane.edu.
Xie D
Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Wang X
Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Baudier RL
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA.
Orlandi P
Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Appel LJ
Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD.
Dember LM
Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
He J
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA.
Kusek JW
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Lash JP
Division of Nephrology, Department of Medicine, University of Illinois at Chicago College of Medicine, Chicago, IL.
Navaneethan SD
Section of Nephrology, Department of Medicine, Baylor University College of Medicine, Houston, TX.
Ojo A
University of Kansas School of Medicine, Kansas City, KS.
Rahman M
Division of Nephrology and Hypertension, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.
Roy J
Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ.
Scialla JJ
Division of Nephrology, Department of Medicine, and Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC; Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA; Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA.
Sondheimer JH
Division of Nephrology and Hypertension, Wayne State University School of Medicine, Detroit.
Steigerwalt SP
Division of Nephrology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI.
Wilson FP
Program of Applied Translational Research, Department of Medicine, Yale University School of Medicine, New Haven, CT.
Wolf M
Division of Nephrology, Department of Medicine, and Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.
Feldman HI
Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
CRIC Study Investigators
No affiliation info available

MeSH

Blood PressureCardiometabolic Risk FactorsChemokine CXCL12Diabetic NephropathiesDisease ProgressionFemaleHumansLife StyleLipocalin-2MaleMiddle AgedPrognosisProspective StudiesRenal Insufficiency, ChronicRisk AssessmentSocioeconomic FactorsUnited States

Pub Type(s)

Clinical Trial
Journal Article
Multicenter Study
Observational Study
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

32866540

Clinical Trial Links

Clinical trial which this article describes

Citation

Anderson, Amanda H., et al. "Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study." American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, vol. 77, no. 1, 2021, pp. 56-73.e1.
Anderson AH, Xie D, Wang X, et al. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021;77(1):56-73.e1.
Anderson, A. H., Xie, D., Wang, X., Baudier, R. L., Orlandi, P., Appel, L. J., Dember, L. M., He, J., Kusek, J. W., Lash, J. P., Navaneethan, S. D., Ojo, A., Rahman, M., Roy, J., Scialla, J. J., Sondheimer, J. H., Steigerwalt, S. P., Wilson, F. P., Wolf, M., & Feldman, H. I. (2021). Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 77(1), 56-e1. https://doi.org/10.1053/j.ajkd.2020.07.011
Anderson AH, et al. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021;77(1):56-73.e1. PubMed PMID: 32866540.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. AU - Anderson,Amanda H, AU - Xie,Dawei, AU - Wang,Xue, AU - Baudier,Robin L, AU - Orlandi,Paula, AU - Appel,Lawrence J, AU - Dember,Laura M, AU - He,Jiang, AU - Kusek,John W, AU - Lash,James P, AU - Navaneethan,Sankar D, AU - Ojo,Akinlolu, AU - Rahman,Mahboob, AU - Roy,Jason, AU - Scialla,Julia J, AU - Sondheimer,James H, AU - Steigerwalt,Susan P, AU - Wilson,F Perry, AU - Wolf,Myles, AU - Feldman,Harold I, AU - ,, Y1 - 2020/08/28/ PY - 2020/01/24/received PY - 2020/07/06/accepted PY - 2022/01/01/pmc-release PY - 2020/9/1/pubmed PY - 2021/2/5/medline PY - 2020/9/1/entrez KW - CKD progression KW - CXCL12 KW - Chronic kidney disease (CKD) KW - N-terminal pro-B-type natriuretic peptide (NTproBNP) KW - diabetes KW - eGFR slope KW - end-stage renal disease (ESRD) KW - estimated glomerular filtration rate (eGFR) KW - halving of eGFR KW - inflammatory chemokines KW - kidney replacement therapy (KRT) KW - neutrophil gelatinase-associated lipocalin (NGAL) KW - renal function trajectory KW - risk stratification SP - 56 EP - 73.e1 JF - American journal of kidney diseases : the official journal of the National Kidney Foundation JO - Am J Kidney Dis VL - 77 IS - 1 N2 - RATIONALE & OBJECTIVE: Identification of novel risk factors for chronic kidney disease (CKD) progression may inform mechanistic investigations and improve identification of high-risk subgroups. The current study aimed to characterize CKD progression across levels of numerous risk factors and identify independent risk factors for CKD progression among those with and without diabetes. STUDY DESIGN: The Chronic Renal Insufficiency Cohort (CRIC) Study is a prospective cohort study of adults with CKD conducted at 7 US clinical centers. SETTING & PARTICIPANTS: Participants (N=3,379) had up to 12.3 years of follow-up; 47% had diabetes. PREDICTORS: 30 risk factors for CKD progression across sociodemographic, behavioral, clinical, and biochemical domains at baseline. OUTCOMES: Study outcomes were estimated glomerular filtration rate (eGFR) slope and the composite of halving of eGFR or initiation of kidney replacement therapy. ANALYTICAL APPROACH: Stepwise selection of independent risk factors was performed stratified by diabetes status using linear mixed-effects and Cox proportional hazards models. RESULTS: Among those without and with diabetes, respectively, mean eGFR slope was-1.4±3.3 and-2.7±4.7mL/min/1.73m2 per year. Among participants with diabetes, multivariable-adjusted hazard of the composite outcome was approximately 2-fold or greater with higher levels of the inflammatory chemokine CXCL12, the cardiac marker N-terminal pro-B-type natriuretic peptide (NT-proBNP), and the kidney injury marker urinary neutrophil gelatinase-associated lipocalin (NGAL). Among those without diabetes, low serum bicarbonate and higher high-sensitivity troponin T, NT-proBNP, and urinary NGAL levels were all significantly associated with a 1.5-fold or greater rate of the composite outcome. LIMITATIONS: The observational study design precludes causal inference. CONCLUSIONS: Strong associations for cardiac markers, plasma CXCL12, and urinary NGAL are comparable to that of systolic blood pressure≥140mm Hg, a well-established risk factor for CKD progression. This warrants further investigation into the potential mechanisms that these markers indicate and opportunities to use them to improve risk stratification. SN - 1523-6838 UR - https://www.unboundmedicine.com/medline/citation/32866540/Novel_Risk_Factors_for_Progression_of_Diabetic_and_Nondiabetic_CKD:_Findings_From_the_Chronic_Renal_Insufficiency_Cohort__CRIC__Study_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0272-6386(20)30925-2 DB - PRIME DP - Unbound Medicine ER -